Physiology and pathophysiology of nitric oxide

Area of Science:

• Biochemistry
• Physiology
• Molecular Biology

Background:

• Nitric oxide (NO) was initially recognized for its vasodilatory and anti-platelet effects before its identification as endothelium-derived relaxing factor (EDRF).
• Subsequent research established EDRF as NO, synthesized by mammalian cells from L-arginine via nitric oxide synthase (NOS).

Purpose of the Study:

• To elucidate the synthesis pathway and physiological mechanisms of nitric oxide (NO).
• To differentiate between constitutive and inducible nitric oxide synthase (NOS) activities and their roles.

Main Methods:

• The study reviews the biochemical pathway of L-arginine oxygenation to NO and L-citrulline catalyzed by NOS.
• It details the cofactors required for NOS activity and the signaling cascade involving guanylate cyclase and cyclic GMP.
• It contrasts the calcium-dependent regulation of constitutive NOS with the calcium-independent induction of high-output NOS.

Main Results:

• Nitric oxide synthase (NOS) catalyzes the conversion of L-arginine to NO and L-citrulline, requiring cofactors like NADPH, FAD, FMN, tetrahydrobiopterin, heme, and calmodulin.
• NO activates guanylate cyclase, increasing cyclic GMP levels and mediating physiological functions.
• Distinct constitutive and inducible NOS isoforms exist, with differing regulatory mechanisms and roles in physiology and pathophysiology.

Conclusions:

• Nitric oxide (NO) plays crucial roles in vasodilation and platelet function, mediated by cyclic GMP.
• Both calcium-dependent constitutive NOS and calcium-independent inducible NOS contribute to NO production with distinct physiological and pathophysiological implications.
• Understanding NOS regulation and NO signaling is vital for comprehending cellular functions and disease processes.